Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,093 public trials 6,471 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

NCT07516093

Conditions
B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Hematology Oncology of Indiana Indianapolis, Indiana, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)

NCT07478991

Conditions
Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Complejo Hospitalario Universitario de A Coruña Santiago de Compostela, A Coruña, Spain
  • ICO Hospitalet- Hospital Duran i Reynals Hospitalet Del Llobregat, Barcelona, Spain
  • Hospital Mútua de Terrassa Terrassa, Barcelona, Spain
  • Complejo Hospitalario de Jaén Jaén, Jaen, Spain
View all 51 locations
View Trial Details
Recruiting

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

NCT05489783

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Glioma, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Elranatamab in R/R Multiple Myeloma

NCT06138275

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

CongenItal Naevus Cohort for Longitudinal Evaluation

NCT06828822

Conditions
Congenital Nevus, Mental Disorders, Naevi, +6 more
Locations
  • Grasse Hospital Nice, Alpes-Maritimes, France
  • Nice University Hospital and Lenval Hospital Nice, Alpes-Maritimes, France
  • Marseille University Hospital Marseille, Bouches-du-Rhône, France
  • Dijon University Hospital Dijon, Côte-d'Or, France
View all 16 locations
View Trial Details
Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NCT05896839

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 26 locations
View Trial Details
Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

NCT06800313

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
  • Sarah Cannon Research Institute 1 Denver, Colorado, United States
View all 18 locations
View Trial Details

Related conditions